MedTrace Logo

Nol-Index Guided Remifentanil Analgesia Versus Standard Analgesia During Moderate-to-High Risk Cardiovascular Surgery

NCT04137991 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2022-07-01

No results posted yet for this study

Summary

This study will investigate the potential of guiding remifentanil analgesia during cardiac and vascular surgery in moderate to high risk patients requiring general anesthesia.

Conditions

  • Nociceptive Pain
  • Goal-directed Therapy
  • Hemodynamic Instability
  • Nol-Index
  • Remifentanil
  • Cardiac Surgery
  • Vascular Surgery
  • General Anesthesia

Interventions

DEVICE

Nol-Index guided analgesia

Monitor that indicates the level of nociception-antinociception balance

OTHER

Standard Analgesia

Administration of remifentanil based guided by heart rate, blood pressure, and experience

Sponsors & Collaborators

  • Erasme University Hospital

    lead OTHER

Principal Investigators

  • Luc Barvais, MD, PhD · Erasme University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-10
Primary Completion
2021-11-01
Completion
2021-11-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04137991 on ClinicalTrials.gov